PUBLISHER: Grand View Research | PRODUCT CODE: 1790122
PUBLISHER: Grand View Research | PRODUCT CODE: 1790122
The U.S. medical tourism market size was estimated at USD 8.74 billion in 2024 and is projected to grow at a CAGR of 13.20% over the forecast period to reach an estimated value of USD 26.58 billion by 2033. The market has experienced significant growth in recent times, driven by the increasing presence of internationally accredited hospitals and the reputation for providing cutting-edge medical treatments. The growing emphasis on personalized and patient-centric care in U.S. healthcare facilities is significantly driving the medical tourism industry in the country.
Hospitals and clinics increasingly focus on tailored treatments to individual patient needs, providing personalized care plans, and enhancing the overall patient experience. This high-quality, patient-centered care is expected to witness high demand from international patients seeking an advanced and customized approach to their health.
The presence of internationally accredited hospitals in the U.S. is driving the growth of the inbound medical tourism. As global patients increasingly prioritize safety, quality, and transparency in their healthcare decisions, the U.S. has positioned itself as a preferred destination by offering facilities that meet stringent international standards. As per the 2023 report by The U.S. Cooperative for International Patient Programs (USCIPP), 60 different U.S. organizations assisted 47,002 international patients and reported gross revenue charges totaling USD 2.1 billion in a single fiscal year. Furthermore, hospitals accredited by globally recognized organizations such as Joint Commission International (JCI), Global Healthcare Accreditation (GHA), and DNV-GL stand out in a competitive medical tourism landscape, offering reassurance to patients regarding care quality and procedural integrity.
Moreover, the presence of internationally trained physicians plays a significant role in supporting the growth of the U.S. inbound medical tourism industry. These physicians, commonly referred to as International Medical Graduates (IMGs), comprise a substantial portion of the national medical workforce. According to The Hospitalist, in 2023, nearly 25 percent of active physicians in the U.S. were IMGs. These physicians originate from a wide range of countries, including India, Pakistan, and Nigeria, and bring with them diverse clinical expertise and multilingual capabilities. These qualities strengthen the clinical workforce and foster a culturally sensitive care environment that is especially valuable for international patients seeking personalized and familiar care experiences.
Furthermore, one of the primary drivers of outbound medical tourism from the U.S. is the exceptionally high cost of healthcare domestically. According to the Centers for Medicare & Medicaid Services (CMS), U.S. national health expenditures reached USD 4.5 trillion in 2022, averaging approximately USD 13,493 per person, accounting for about 17.3 percent of GDP. These figures underscore the steep financial burden of healthcare in the U.S.
Meanwhile, the U.S. Census Bureau reports that roughly 8 percent of the U.S. population remained uninsured in 2023, with a similar proportion, 92 percent, insured at some point during the year. Even those who are insured often encounter high deductibles, copayments, or coinsurance, making many vital treatments financially inaccessible.
U.S. Medical Tourism Market Report Segmentation
This report forecasts revenue growth, country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. medical tourism market report based on type.